ME1 Meet the expert
Biomarkers for interstitial lung disease - FULLY BOOKED
Translational
Registration for this session is additional to the congress registration fee and is €100 on site, €90 standard or €70 for early bird registration.
Aims : Access educational materials here
To critically review the most recent findings in interstitial lung disease (ILD) biomarker research including discovery tools; and to understand how biomarkers could be used to clinically manage specific forms of ILD such as idiopathic pulmonary fibrosis (IPF) or connective tissue disease (CTD)-ILD.
Target audience :
Immunologist, Pharmaceutical industry representative, Pulmonologist, Researcher, Resident, Scientist
13:00
Biomarkers for interstitial lung disease
M. Kolb(Hamilton (ON), Canada)
COI
1
1422
13:40
Interview by a junior member
M. Platé(London, United Kingdom)
COI
2
. . .
